On the other hand, in prostate cancer the acetylation on H2A.Z (K4, K7, and K11) allows greater chromatin accessibility, contributing to the activation of androgen receptor-associated enhancers and gene expression (12). The gene discussed is AR; the disease is prostate cancer.